Evommune (EVMN US)

Evommune, Inc.operates as a clinical-stage biotechnology company. The Company focuses on the developing therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Evommune serves customers worldwide.